Characterization of isavuconazole pharmacokinetics and pharmacodynamics in a real-life cohort. (PubMed, JAC Antimicrob Resist) - May 6, 2026 - "Our results indicate that ISA exposure shows substantial variability and tends to correlate with outcome. This suggests a beneficial role for TDM in optimizing target achievement."
Journal • PK/PD data • Infectious Disease • Pulmonary Disease • Respiratory Diseases
|
|
Dionysios Neofytos; Frederic Lamoth; Ilana Reinhold; Ilona Kronig; Jade Couchepin; Monia Guidi; Pascal André; Peter Werner Schreiber; Thierry Buclin
|